Clinical Trial Update: Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin [Phase 2]

View source ↗

Summary

Phase 2 trial update for bendamustine in patients with classical Hodgkin lymphoma treated with prednisone, vinblastine, and doxorubicin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classical Hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Classical Hodgkin Lymphoma | Phase 2 | Status: COMPLETED